Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.810
+0.050 (1.05%)
At close: May 9, 2025, 4:00 PM
4.860
+0.050 (1.04%)
After-hours: May 9, 2025, 7:09 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $236.99 million as of May 9, 2025. Its market cap has increased by 33.47% in one year.
Market Cap
236.99M
Enterprise Value
147.80M
1-Year Change
33.47%
Ranking
Category
Stock Price
$4.81
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $236.99M, an increase of 6.56%. That is a compound annual growth rate of 1.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 236.99M | -35.72% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 350.94B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |